Malaria drug fails to prevent COVID-19 in a rigorous study
After 14 days in the study, 12% on the drug developed COVID-19 symptoms versus 14% in the placebo group, but the difference is so small it could have occurred by chance.
from Section Page News - Modern Healthcare https://ift.tt/2MojhK8
via IFTTT
No comments:
Post a Comment